Abstract
Liposomes that have been injected parenterally into animals have a well-known natural tendency to be ingested rapidly and in large amounts by macrophages. Uptake of liposomes by macrophages has often been cited as a potential hurdle that could theoretically block applications of liposomes as drug carriers for certain purposes. However, the macrophage itself has served as a target for delivery of liposome-encapsulated drugs and immunomodulators, particularly for treatment of infectious diseases and cancer (Alving, 1983, 1989; Fidler, 1985; Swenson et al, 1988). It is certainly true that overcoming of the macrophage as an “obstacle” can be difficult, but several reports have indicated that increased blood circulation time and distribution of liposomes to certain tissues can be achieved by the use of special biophysically or biochemically tailored liposomes (Hwang et al, 1980; Gregoriadis et al, 1982; Allen and Chonn, 1987; Papahadjopoulos and Gabizon, 1987; Gabizon and Papahadjopoulos, 1988).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, T.M. and Chonn, A., 1987, Large unilamellar liposomes with low uptake into the reticuloendothelial system, FEBS.Lett., 223: 42.
Alving, C.R., 1989, Macrophages as targets for delivery of liposomeencapsulated antimicrobial drugs, Advanced Drug Deliv. Rev. (in press).
Alving, C.R., 1987, Liposomes as carriers of vaccines, in: “Liposomes from Biophysics to Therapeutics”, M.J. Ostro, ed., Marcel Dekker, Inc., New York.
Alving, C.R., Richards, R.L., Moss, J., Alving, L.I., Clements, J.D., Shiba, T., Kotani, S., Wirtz, R.A. and Hockmeyer, W.T., 1986, Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite vaccine, Vaccine, 4: 166.
Alving, C.R., 1983, Delivery of liposome-encapsulated drugs to macrophages, Pharmacol.Therap., 22: 407.
Ballou, W.R., Rothbard, J., Wirtz, R.A., Gordon, D.M., Williams, J.S., Gore, R.W., Schneider, I., Hollingdale, M.R., Beaudoin, R.L., Maloy, W.L., Miller, L.H. and Hockmeyer, W.T., 1985, Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum, Science, 228: 996.
Ballou, W.R., Hoffman, S.L., Sherwood, J.A., Hollingdale, M.R., Neva, F.A., Hockmeyer, W.T., Gordon, D.M., Schneider, I., Wirtz, R.A., Young, J.F., Wasserman, CF., Reeve, P., Diggs, CL. and Chulay, J.D., 1987, Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine, Lancet i (June 6): 1277.
Beatty, J.D., Beatty, B.C, Paraskevas, F. and Froese, E., 1984, Liposomes as immune adjuvants: T cell dependence, Surgery, 96: 345.
Clyde, D.F., McCarthy, V.C, Miller, R.M. and Woodward, W.E., 1975, Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites, Am.J.Trop.Med.Hyg., 24: 397.
Dame, J.B., Williams, J.L., McCutchan, T.F., Weber, J.L., Wirtz, R.A., Hockmeyer, W.T. Maloy, W.L., Haynes, J.D., Schneider, I., Roberts, D., Sanders, G.S., Reddy, E.P., Diggs, C.L. and Miller, L.H., 1984, Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum, Science, 225: 593.
Egan, J.E., Weber, J.L., Ballou, W.R., Hollingdale, M.R., Majarian, W.R., Gordon, D.M., Maloy, W.L., Hoffman, S.L., Wirtz, R.A., Schneider, I., Woollett, C.R., Young, J.F. and Hockmeyer, W.T., 1987, Efficacy of murine malaria sporozoite vaccines: Implications for human vaccine development, Science, 236: 453.
Fidler, I.J., 1985, Macrophages and metastasis-A biological approach to cancer therapy: Presidential address, Canc.Res., 45: 4714.
Gabizon, A. and Papahad jopoulos, D., 1988, Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors, Proc. Natl. Acad. Sci. U.S.A., 85: 6949.
Gregoriadis, G., Kirby, C., Large, P., Meehan, A. and Senior, J., 1982, Targeting of liposomes: Study of influencing factors, in: “Targeting of Drugs”, C Gregoriadis, J. Senior and A. Trouet, eds., Plenum, New York.
Herrington, D.A., Clyde, D.F., Losonsky, G., Cortesia, M., Murphy, J.R., Davis, J., Baqar, S., Felix, A.M., Heimer, E.P., Gillessen, D., Nardin, E., Nussenzweig, R.S., Nussenzweig, V., Hollingdale, M.R. and Levine, M.R., 1987, Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites, Nature, 328: 257.
Hoffman, S.L., Wistar, Jr., R., Ballou, W.R., Hollingdale, M.R., Wirtz, R.A., Schneider, I., Marwoto, H.A. and Hockmeyer, W.T., 1986, Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum, New Eng. J. Med., 315: 601.
Hoffman, S.L., Oster, C.N., Plowe, C.V., Woollett, G.R., Beier, J.C., Chulay, J.D., Wirtz, R.A., Hollingdale, M.R. and Mugambi, M., 1987, Naturally acquired antibodies to sporozoites do not prevent malaria: Vaccine development implications, Science, 237: 639
Hwarang, K.J., Luk, K.S. and Beaumier, P.L., 1980, Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: A kinetic study, Proc.Natl.Acad.Sci., 77: 4030.
Nussenzweig, R., Vanderberg, J. and Most, H., 1969, Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. TV. Dose response, specificity and humoral immunity, Milit. Med., 134: 1176.
Papahadjopoulos, D. and Gabizon, A., 1987, Targeting of liposomes to tumor cells in vitro, Ann.N.Y.Acad.Sci., 507: 64.
Potocnjak, P., Yoshida, N., Nussenzweig, R.S. and Nussenzweig, V., 1980, Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection, J.Exp.Med., 151: 1504.
Richards, R.L., Hayre, M.D., Hockmeyer, W.T. and Alving, C.R., 1988, Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen, Infect.Immun., 56: 682.
Rieckmann, K.H., Beaudoin, R.L., Cassells, J.S. and Sell, K.W., 1979, Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria, Bull.W.H.O., 57(Suppl. 1): 261.
Shek, P.N. and Lukovich, S., 1982, The role of macrophages in promoting the antibody response mediated by liposome-associated antigens, Immunol. Lett., 5: 305.
Steinman, R.M. and Nussenzweig, M.C., 1980, Dendritic cells: Features and functions, Immunol.Rev., 53: 129.
Swenson, C.E., Popescu, M.C. and Ginsberg, R.S., 1988, Preparation and use of liposomes in the treatment of microbial infections, C.R.C.Crit. Rev.Microbiol., 15(Suppl. 1): 81.
Tew, J.G., Phipps, R.P. and Mandel, T.E., 1980, The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells, Immunol. Rev., 53: 175.
Uhanue, E.R., 1984, Antigen-presenting function of the macrophage, Ann. Rev. Immunol., 2: 395.
Uhanue, E.R. and Allen, P.M., 1987, The basis for the immunoregulatory role of macrophages and other accessory cells, Science, 236: 551.
Webster, H.K., Boudreau, E.F., Pang, L.W., Permpanich, B., Sookto, P. and Wirtz, R.A., 1987, Development of immunity in natural Plasmodium falciparum malaria: Antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32), J.Clin.Microbiol., 25: 1002.
Wirtz, R.A., Ballou, W.R., Schneider, I., Chedid, L., Gross, M.J., Young, J.F., Hollingdale, M., Diggs, C.L. and Hockmeyer, W.T., 1987, Plasmodium falciparum: Immunogenicity of circumsporozoite protein constructs produced in Escherichia coli, Exp.Parasitol., 63: 166.
Young, J.F., Hockmeyer, W.T., Gross, M., Ballou, W.R., Wirtz, R.A., Trosper, J.H., Beaudoin, R.L., Hollingdale, M.R., Miller, L.H., Diggs, C.L. and Rosenberg, M., 1985, Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine, Science, 228: 958.
Zavala, F., Tarn, J.P., Hollingdale, M.R., Cochrane, A.H., Quakyi, I., Nussenzweig, R.S. and Nussenzweig, V., 1985, Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria, Science, 228: 1436.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Alving, C.R., Richards, R.L., Hayre, M.D., Hockmeyer, W.T., Wirtz, R.A. (1989). Liposomes as Carriers of Vaccines: Development of a Liposomal Malaria Vaccine. In: Gregoriadis, G., Allison, A.C., Poste, G. (eds) Immunological Adjuvants and Vaccines. NATO ASI Series, vol 179. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0283-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0283-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0285-9
Online ISBN: 978-1-4757-0283-5
eBook Packages: Springer Book Archive